Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment

被引：0
|
作者：
Rafael Morales-Barrera
Guillermo Villacampa
Natalia Vidal
Mariona Figols
Julia Giner
Teresa Bonfill
Cristina Suárez
Nely Díaz
Joaquín Mateo
Macarena González
Montserrat Domenech
Javier Puente
Joan Carles
机构：
[1] Vall d’Hebron Institute of Oncology,Department of Medical Oncology
[2] Vall d’ Hebron University Hospital,Oncology Data Science (OdysSey) Group
[3] Universitat Autònoma de Barcelona,Medical Oncology Department
[4] Vall d’Hebron Institute of Oncology (VHIO),Medical Oncology Department
[5] The Institute of Cancer Research,Medical Oncology
[6] Hospital Clínico San Carlos,undefined
[7] Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),undefined
[8] CIBERONC,undefined
[9] Fundació Althaia Manresa,undefined
[10] Parc Taulí Hospital Universitari,undefined
[11] Institut d’Investigació i Innovació Parc Taulí I3PT,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Immune checkpoint inhibitors; Immune-related adverse events; Overall response rate; Survival; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3556 / 3564
页数：8
相关论文
共 50 条
  • [21] Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Therapy
    Ho, Adrienne K.
    Ho, Anthony M-H
    Cooksley, Tim
    Nguyen, Giang
    Erb, Jason
    Mizubuti, Glenio B.
    ANESTHESIA AND ANALGESIA, 2021, 132 (02): : 374 - 383
  • [22] Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients.
    Rodriguez, Benigno
    Martinez-Herrera, Jose Fabian
    Zepeda, Lorena Lopez
    Olivares, Guillermo
    Villalobos, Alberto
    Perez, Fernando
    Limas, Christian Patricio Camacho
    Serrano, Juan Alberto
    Villamayor, Omar Serrano
    Lopez, Ervin Saul Enciso
    Gerson, Daniela Shveid
    Sanchez, Efrain Isaias Camarin
    Molina, Diana Bonilla
    Cabrera, Juan Manuel Tovar
    Nehmad, Cecilia
    Whaley, Juan Jose Juarez -Vignon
    Gerson, Raquel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Immune-related cutaneous adverse events associated with immune-checkpoint inhibitors: Our experience
    Pinilla-Martin, Belen
    Sanchez-Velazquez, Alba
    Vico-Alonso, Cristina
    Aragon-Miguel, Raquel
    Calleja-Algarra, Alba
    Jose Andres-Lencina, Juan
    Burillo-Martinez, Sara
    Tous-Romero, Fatima
    Maronas-Jimenez, Lidia
    Luis Ortiz-Romero, Pablo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB223 - AB223
  • [24] Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
    Sophia B. Strobel
    Devayani Machiraju
    Katharina A. Kälber
    Jessica C. Hassel
    Cancer Immunology, Immunotherapy, 2022, 71 : 2051 - 2056
  • [25] Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience
    Samanci, N. S.
    Oruc, K.
    Bedir, S.
    Celik, E.
    Degerli, E.
    Derin, S.
    Demirelli, F. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) due to immune-related adverse events (irAEs).
    Nizam, Amanda
    Sheng, Iris Yeong-Fung
    Allman, Kimberly D.
    Martin, Allison
    Gilligan, Timothy D.
    Gupta, Shilpa
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [27] Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
    Strobel, Sophia B.
    Machiraju, Devayani
    Kaelber, Katharina A.
    Hassel, Jessica C.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 2051 - 2056
  • [28] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [29] Letter regarding "Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma"
    Wang, Yinhan
    Huang, Yongfa
    Yang, Huayu
    Mao, Yilei
    LIVER CANCER, 2023, 12 (01) : 85 - 86
  • [30] Clinical Presentation of Immune-Related Endocrine Adverse Events during Immune Checkpoint Inhibitor Treatment
    Chieng, Jenny Hui Ling
    Htet, Zaw Win
    Zhao, Joseph J.
    Tai, E. Shyong
    Tay, Sen Hee
    Huang, Yiqing
    Wong, Alvin
    Yang, Samantha Peiling
    CANCERS, 2022, 14 (11)
12345